|
|
Article: DURAMED AND SCHEIN COMPLETE AGREEMENT FOR CONJUGATED ESTROGENS DEVELOPMENT
- Article from:
- PR Newswire
- Article date:
- June 29, 1992
CopyrightCOPYRIGHT 1992 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DURAMED AND SCHEIN COMPLETE AGREEMENT FOR
CONJUGATED ESTROGENS DEVELOPMENT
CINCINNATI, June 29 /PRNewswire/ -- E. Thomas Arington, chairman and president of Duramed Pharmaceuticals, Inc. (NASDAQ: DRMD), and Martin Sperber, chairman of Schein Pharmaceutical Inc., today announced the signing of the definitive agreement for the development, manufacturing and marketing of a new formulation of Conjugated Estrogens Tablets, the generic equivalent to the brand product Premarin. This agreement is pursuant to the letter of intent announced on March 2, 1992. This new formulation is being designed to meet bioequivalence guidance established by the Food and ...